ロード中...
Non-antigenic and antigenic interventions in type 1 diabetes
Type 1 diabetes (T1D) results from autoimmune destruction of the pancreatic β-cells. Current T1D therapies are exclusively focused on regulating glycemia rather than the underlying immune response. A handful of trials have sought to alter the clinical course of T1D using various broad immune-suppres...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896560/ https://ncbi.nlm.nih.gov/pubmed/24165565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26890 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|